Immunosuppression minimization protocols: How should they be monitored?

Nature Clinical Practice Nephrology

Volumn 4, Issue 9, 2008, Pages 484-485

  Akalin, Enver ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; ALEMTUZUMAB; ANTIBODY; CYCLOSPORIN; DONOR SPECIFIC ANTIGEN; HLA ANTIGEN; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; BIOPSY; DESENSITIZATION; DRUG ACTIVITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MONITORING; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOLOGICAL MONITORING; IMMUNOSUPPRESSION MINIMIZATION PROTOCOL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY DONOR; KIDNEY GRAFT; LOW DRUG DOSE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NOTE; PATIENT MONITORING; PATIENT SELECTION; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

EID: 50249172841     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0910     Document Type: Note

References (6)

1. Shapiro R et al. (2008) Alemtuzumab preconditioning with tacrolimus monotherapy - the impact of serial monitoring for donor-specific antibody. Transplantation 85: 1125-1132
2. Ciancio G and Burke GW 3rd (2008) Alemtuzumab (Campath-1H) in kidney transplantation. Am J Transplant 8: 15-20
3. Shapiro R et al. (2003) Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg 238: 520-525
4. Akalin E and Pascual M (2006) Sensitization after kidney transplantation. Clin J Am Soc Nephrol 1: 433-440
5. Akalin E and Watschinger B (2007) Antibody-mediated rejection. Semin Nephrol 27: 393-407
6. Brouard S et al. (2007) Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci USA 104: 15448-15453